Showing 1151-1160 of 9143 results for "".
Dr. Chan Discusses Experience with Gemini Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-chan-discusses-experience-with-gemini-laser/19471/“Gemini is an extremely effective non-ablative skin rejuvenation laser. And by combining the 532 KTP lasers with the long pulse 1064 YAG, we can achieve non-ablative skin rejuvenations in terms of reductions of pigmentations, fine lines, pore size and vessel improvement.” & #8212Professor HenryILDS Joins the Lancet Commission on Skin Health
https://practicaldermatology.com/series/skin-minute/ilds-joins-the-lancet-commission-on-skin-health/57085/Esther Freeman, MD, talks about the International League of Dermatologic Society (ILDS) and its new contributions to one of The Lancet’s new Commission focusing exclusively on skin health. It’s the first time the publication has devoted one of its highly regarded Commissions on skin health.Complicated Diagnostics and Treatments
https://practicaldermatology.com/conferences/noah-worcester/complicated-diagnostics-and-treatments/57072/Linda Susan Marcus, MD, discusses her presentation, “Difficult Management Cases and Multidisciplinary Implications,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Chemical Peels for Periocular Lentigines
https://practicaldermatology.com/conferences/noah-worcester/chemical-peels-for-periocular-lentigines/57073/Kachiu Lee, MD, MPH, discusses her presentation, “Treatment of Periocular Lentigines with Chemical Peels: A Clinical Pearl,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Promising New Data on Clascoterone for Androgenetic Alopecia
https://practicaldermatology.com/series/c-suite-chats/promising-new-data-on-clascoterone-for-androgenetic-alopecia/56939/Cosmo Pharmaceuticals CEO Giovanni Di Napoli discusses the challenges posed by androgenetic alopecia (AGA) and the potential impact of a clascoterone 5% topical solution based on new Phase 3 data.Comparing Sunscreen for Skin of Color: Print-Ready Charts for Download
https://practicaldermatology.com/topics/skin-cancer-photoprotection/comparing-sunscreen-for-skin-of-color-print-ready-charts/56515/Click the image to download the print-ready PDFsCommitment to Clinical Evidence in Regenerative Aesthetics
https://practicaldermatology.com/series/c-suite-chats/commitment-to-clinical-evidence-in-regenerative-aesthetics/54693/Laura Ellis, MD, CEO and Co-Founder of LevEllis, Inc., discusses the current state of aesthetic regenerative medicine and the importance of clinical evidence as the field continues to advance.Connections for the Future of Dermatology
https://practicaldermatology.com/series/skin-minute/connections-for-the-future-of-dermatology/54688/Frederick Beddingfield, MD, PhD, recaps the Dermatology Summit 2026, a meeting to connect innovators and investors in the field of dermatology.Wound Closure After Mohs Surgery
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/wound-closure-after-mohs-surgery/54648/Anna Bar, MD, discusses key takeaways from the “Wound Closures” workshop at Maui Derm Hawaii 2026.Addressing Itch in Prurigo Nodularis Clinical Trials
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37170/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, addresses how future prurigo nodularis trials could better address the heterogeneity in disease burden and patient-reported outcomes.